miR-505 suppresses prostate cancer progression by targeting NRCAM

por Ling, Xiao-Hui, Fu, Hao, Chen, Zhi-Yun, Lu, Jian-Ming, Zhuo, Yang-Jia, Chen, Jia-Hong, Zhong, Wei-De, Jia, Zhenyu
Publicado 2019

miR-505 suppresses prostate cancer progression by targeting NRCAM

por Ling, Xiao-Hui, Fu, Hao, Chen, Zhi-Yun, Lu, Jian-Ming, Zhuo, Yang-Jia, Chen, Jia-Hong, Zhong, Wei-De, Jia, Zhenyu
Publicado 2020

Novel immune‐related signature for risk stratification and prognosis in prostatic adenocarcinoma

por Zhao, Hai‐Bo, Zeng, Yan‐Ru, Han, Zhao‐Dong, Zhuo, Yang‐Jia, Liang, Ying‐Ke, Hon, Chi Tin, Wan, Song, Wu, Shulin, Dahl, Douglas, Zhong, Wei‐De, Wu, Chin‐Lee
Publicado 2021

Overexpression of NIMA-related kinase 2 is associated with progression and poor prognosis of prostate cancer

por Zeng, Yan-Ru, Han, Zhao-Dong, Wang, Cong, Cai, Chao, Huang, Ya-Qiang, Luo, Hong-Wei, Liu, Ze-Zhen, Zhuo, Yang-Jia, Dai, Qi-Shan, Zhao, Hai-Bo, Liang, Yu-Xiang, Zhong, Wei-De
Publicado 2015

Tumor Suppressor Role and Clinical Significance of the FEV Gene in Prostate Cancer

por Liang, Yu-Xiang, Liang, Ying-Ke, Zou, Zhi-Hao, Zhuo, Yang-Jia, Ye, Jian-Heng, Zhu, Xue-Jin, Cai, Zhou-Da, Lin, Zhuo-Yuan, Mo, Ru-Jun, Wu, Shu-Lin, Zhang, Yan-Qiong, Zhong, Wei-De
Publicado 2022

Retraction Note: MicroRNA-30d promotes angiogenesis and tumor growth via MYPT1/c-JUN/VEGFA pathway and predicts aggressive outcome in prostate cancer

por Lin, Zhuo-yuan, Chen, Guo, Zhang, Yan-qiong, He, Hui-chan, Liang, Yu-xiang, Ye, Jian-heng, Liang, Ying-ke, Mo, Ru-jun, Lu, Jian-ming, Zhuo, Yang-jia, Zheng, Yu, Jiang, Fu-neng, Han, Zhao-dong, Wu, Shu-lin, Zhong, Wei-de, Wu, Chin-Lee
Publicado 2023

MicroRNA-30d promotes angiogenesis and tumor growth via MYPT1/c-JUN/VEGFA pathway and predicts aggressive outcome in prostate cancer

por Lin, Zhuo-yuan, Chen, Guo, Zhang, Yan-qiong, He, Hui-chan, Liang, Yu-xiang, Ye, Jian-heng, Liang, Ying-ke, Mo, Ru-jun, Lu, Jian-ming, Zhuo, Yang-jia, Zheng, Yu, Jiang, Fu-neng, Han, Zhao-dong, Wu, Shu-lin, Zhong, Wei-de, Wu, Chin-Lee
Publicado 2017

Correction to: MicroRNA-30d promotes angiogenesis and tumor growth via MYPT1/c-JUN/VEGFA pathway and predicts aggressive outcome in prostate cancer

por Lin, Zhuo-yuan, Chen, Guo, Zhang, Yan-qiong, He, Hui-chan, Liang, Yu-xiang, Ye, Jian-heng, Liang, Ying-ke, Mo, Ru-jun, Lu, Jian-ming, Zhuo, Yang-jia, Zheng, Yu, Jiang, Fu-neng, Han, Zhao-dong, Wu, Shu-lin, Zhong, Wei-de, Wu, Chin-Lee
Publicado 2019